Radius Health Obtains $91,000,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b60d3a0f-47cb-45a1-a210-d8db4b93c86a&Preview=1 -
Date
5/24/2011 -
Company Name
Radius Health -
Mailing Address
300 Technology Square Fifth Floor Cambridge, MA 02139 -
Company Description
Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women’s health. -
Website
http://www.radiuspharm.com -
Transaction Type
Debt, Venture Equity -
Transaction Amount
$91,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Radius will use the proceeds primarily to fund Phase 3 clinical development of the subcutaneous injection form of BA058, the company’s novel, proprietary PTHrP (parathyroid hormone-related protein) analog, for the treatment of osteoporosis. -
M&A Terms
-
Venture Investor
GE Healthare Financial Services -
Venture Investor
Oxford Finance Corporation -
Venture Investor
BB Biotech Ventures -
Venture Investor
Brookside Capital -
Venture Investor
Saints Capital -
Venture Investor
Nordic Biotech Advisors -
Venture Investor
MPM Capital -
Venture Investor
The Wellcome Trust -
Venture Investor
HealthCare Ventures -
Venture Investor
Scottish Widows Investment Partnership
